Abstract
To evaluate the prevalence of peri-implant diseases and to identify risk/protective indicators of peri-implantitis. Two hundred and forty randomly selected patients from a university clinic database were invited to participate. Those who accepted, once data from their medical and dental history were collected, were examined clinically and radiographically to assess the prevalence of peri-implant health and diseases. Peri-implantitis was defined as the presence of BoP/SoP together with radiographic bone levels (BL) ≧2mm. An intermediate peri-implant health category between peri-implant mucositis and peri-implantitis was also identified, defined by the presence of BoP/SoP together with 1mm ≦BL<2mm. A multilevel multivariate logistic regression analysis was carried out to identify those factors associated either positively (risk) or negatively (protective) with peri-implantitis. Ninety-nine patients with a total of 458 dental implants were analyzed. The prevalences of pre-periimplantitis and of peri-implantitis were, respectively, 31.3% and 56.6% at patient-level, while 31.7% and 27.9% at implant level. The following factors were identified as risk indicators for peri-implantitis: smoking (OR=3.59; 95% CI: 1.52-8.45), moderate/severe periodontitis (OR=2.77; 95% CI: 1.20-6.36), <16 remaining teeth (OR=2.23; 95% CI: 1.05-4.73), plaque (OR=3.49; 95% CI: 1.13-10.75), implant malposition (too vestibular: OR=2.85; 95% CI: 1.17-6.93), implant brand (Nobel vs. Straumann: OR=4.41;95% CI: 1.76-11.09), restoration type (bridge vs. single crown: OR=2.47; 95% CI: 1.19-5.12), and trauma as reason of tooth loss (vs. caries: OR=6.51; 95% CI: 1.45-29.26). Conversely, the following factors were identified as protective indicators: interproximal flossing/brushing (OR=0.27; 95% CI: 0.11-0.68), proton pump inhibitors (OR=0.08; 95% CI: 0.01-0.90), and anticoagulants (OR=0.08; 95% CI: 0.01-0.56). Peri-implant diseases are highly prevalent among patients with dental implants in this university-based population. Several factors were identified as risk- and protective- indicators of peri-implantitis.
Highlights
Peri-implantitis has been defined in the 2017 World Workshop as a plaque‐associated pathological condition affecting tissues around dental implants, characterized by inflammation in the peri‐implant mucosa and subsequent progressive loss of supporting bone (Berglundh et al, 2018a; Schwarz, Derks, Monje, & Wang, 2018)
The following factors were identified as risk indicators for periimplantitis: smoking (OR=3.59; 95%CI:1.52-8.45), moderate/severe periodontitis (OR=2.77; 95%CI:1.20-6.36),
Several factors were identified as risk- and protective-indicators of peri-implantitis
Summary
Peri-implantitis has been defined in the 2017 World Workshop as a plaque‐associated pathological condition affecting tissues around dental implants, characterized by inflammation in the peri‐implant mucosa and subsequent progressive loss of supporting bone (Berglundh et al, 2018a; Schwarz, Derks, Monje, & Wang, 2018). Despite different non-surgical and surgical treatment strategies proposed for treating periimplantitis, disease resolution is seldom the long-term outcome and even when achieved, recurrence may occur (Berglundh, Wennström, & Lindhe, 2018b; Carcuac et al, 2017; Cha, Lee, & Kim, 2019; de Tapia et al, 2019; Figuero, Graziani, Sanz, Herrera, & Sanz, 2014; Heitz-Mayfield et al, 2018; Nart et al, 2020; Ravidà, Saleh, et al, 2020b; Roccuzzo, Layton, Roccuzzo, & HeitzMayfield, 2018) In light of this limited predictability, its prevention becomes of uttermost importance. A fundamental thrive in current implant research is the identification of further risk factors and indicators of peri-implant diseases
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.